Each year in the U.S, approximately 75,000 patients undergo surgery to remove cytologically indeterminate thyroid nodules—small growths of cells near their thyroid gland that can’t be classified as benign or malignant with a traditional biopsy
But David Steward, MD, UC Professor of Otolaryngology and Endocrinology and a member of the UC Neurosensory Disorders Center, recently participated in a study that could exclude up to a third of those patients from surgery by using a new gene-expression test to rule out malignancy.
The results of the study, “Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology,” were published in the June 25 issue of the New England Journal of Medicine.
Dr. Steward is a co-author of the study.
Learn more >>
